Teri F. Willey - Managing Partner
email: tfw@archdp.com

Teri's current professional focus is equity based deal structure in commercializing university-based bioscience. She is formerly a member of the Board of Directors of Rubicon Genomics, Inc., PanCel Corporation and NephRx Corporation and an Advisor to Endocyte, Inc., Spring Mill Ventures and the Van Andel Research Institute. Prior to the start of ARCH Development Partners, she was most recently Vice President of Start-ups at ARCH Development Corporation, a subsidiary of the University of Chicago, which commercialized technology from the University and Argonne National Laboratory. Teri has extensive experience in technology commercialization stemming not only from her work with Arch Development Corporation, but also from performing similar work for Northwestern University and Purdue University. Teri is a past President of the Association of University Technology Managers (AUTM).